Clinical Trial Update: TELI TON - Telithromycin in Tonsillitis [Phase 3]

View source ↗

Summary

A Phase 3 trial of telithromycin for tonsillitis and pharyngitis sponsored by Sanofi has been terminated; no study results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pharyngitis
• Tonsillitis

Drugs mentioned

• Ketek (telithromycin)
• Telithromycin (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Tonsillitis, Pharyngitis | Phase 3 | Status: TERMINATED